Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Vet Microbiol ; 158(3-4): 425-30, 2012 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-22410309

RESUMO

Nocardioform placentitis associated with gram positive branching actinomycetes caused a record number of abortions in mares diagnosed by the University of Kentucky Veterinary Diagnostic Laboratory (UKVDL) affecting the 2011 foal crop (2011 foal crop: the cohort of foals conceived during the 2010 breeding season). The goal of the present study is to make a comprehensive analysis of this outbreak in terms of frequencies of the bacteria causing nocardioform placentitis mediated abortions and to investigate the ages of fetuses, abortion months and breeding times. In the present study, characteristic slow-growing, pungent/soil odor gram positive branching actinomycetes were recovered in high numbers in placental specimens in 76 abortion cases diagnosed as nocardioform placentitis by pathologists. To determine the type of actinomycetes responsible for the abortions, PCR assays were performed on the gram positive branching bacilli. The most prominent actinomycetes species were Amycolatopsis spp. (37 cases, 48.7%) and Crossiella equi (C. equi) (22 cases, 28.9%). Six cases (7.9%) contained both Amycolatopsis spp., and C. equi. 10 isolates were unidentified by PCR assays and shown to have high DNA sequence homology to Streptomyces species, Microbacterium species, Nocardia species and Allokutzneria species, as evidenced by 16 rRNA gene sequencing and phylogenetic analysis. Nocardioform placentitis related abortions occurred mostly between December 2010 and April 2011 happening exclusively in the last trimester. Breeding time of aborted pregnancies ranged from March 2010 to July 2010, suggesting that if transmission of the actinomycetes agents occurred during breeding, it was not related to a specific season.


Assuntos
Aborto Animal/microbiologia , Infecções por Actinomycetales/veterinária , Surtos de Doenças/veterinária , Doenças dos Cavalos/epidemiologia , Doenças Placentárias/microbiologia , Aborto Animal/epidemiologia , Actinomycetales/genética , Actinomycetales/isolamento & purificação , Infecções por Actinomycetales/microbiologia , Animais , Bactérias/genética , Bactérias/isolamento & purificação , Feminino , Doenças dos Cavalos/microbiologia , Cavalos , Kentucky/epidemiologia , Filogenia , Placenta/microbiologia , Doenças Placentárias/epidemiologia , Gravidez , RNA Ribossômico 16S/genética
2.
J Vet Diagn Invest ; 24(6): 1158-61, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23051830

RESUMO

Nocardioform actinomycetes are significant causes of placentitis and abortions in horses. In the current study, antimicrobial susceptibility patterns of 38 Amycolatopsis spp. and 22 Crossiella equi isolates, the most common nocardioform actinomycetes causing placentitis in horses, were evaluated. Antimicrobial susceptibilities of these isolates were tested by broth microdilution method in a commercial system, which was designed for Nocardia spp., fast-growing Mycobacterium spp., and other aerobic actinomycetes. The minimum inhibitory concentration required to inhibit the growth of 90% of organisms (MIC(90)) of the following antibiotics tested for Amycolatopsis spp. were: 4 µg/ml for linezolid, trimethophrim-sulfametaxazole (TMP-SMX), and ciprofloxacin; 8 µg/ml for ceftriaxone, doxycycline, and minocycline; 16 µg/ml for amoxicillin-clavulanic acid, clarithromycin, and imipenem; >16 µg/ml for tobramycin; 32 µg/ml for amikacin and cefepime; and 128 µg/ml for cefoxitin. The MIC(90) levels for C. equi were 0.25 µg/ml for doxycycline; ≤1 µg/ml for minocycline; 2 µg/ml for linezolid and TMP-SMX; 4 µg/ml for ciprofloxacin; 8 µg/ml for amoxicillin-clavulanic acid, ceftriaxone, and imipenem; 16 µg/ml for clarithromycin; >16 µg/ml for tobramycin; 32 µg/ml for cefepime; >64 µg/ml for amikacin; and 128 µg/ml for cefoxitin.


Assuntos
Actinobacteria/efeitos dos fármacos , Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Infecções por Bactérias Gram-Positivas/veterinária , Doenças Placentárias/veterinária , Complicações Infecciosas na Gravidez/veterinária , Actinobacteria/classificação , Animais , Feminino , Infecções por Bactérias Gram-Positivas/microbiologia , Cavalos , Testes de Sensibilidade Microbiana , Doenças Placentárias/microbiologia , Gravidez , Complicações Infecciosas na Gravidez/microbiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa